AAPL346.95+3.04 (+0.88%) ▲|ABBV286.48-0.26 (-0.09%) ▼|ABT103.40-1.48 (-1.41%) ▼|ACN236.25-10.98 (-4.44%) ▼|ADBE251.12-7.50 (-2.90%) ▼|AMAT398.08+10.49 (+2.71%) ▲|AMD558.56+27.28 (+5.13%) ▲|AMGN447.01+2.38 (+0.53%) ▲|AMT185.93-2.35 (-1.25%) ▼|AMZN253.31+4.22 (+1.69%) ▲|AVGO341.61+12.44 (+3.78%) ▲|AXP314.18-0.88 (-0.28%) ▼|BA169.85-18.46 (-9.80%) ▼|BAC50.60+0.08 (+0.16%) ▲|BKNG151.78-1.36 (-0.89%) ▼|BLK1,134.93+7.27 (+0.64%) ▲|BMY61.34-0.27 (-0.44%) ▼|BNY147.83+0.65 (+0.44%) ▲|BRK-B544.77-3.79 (-0.69%) ▼|C122.63+1.59 (+1.31%) ▲|CAT712.52+20.39 (+2.95%) ▲|CL92.17-0.94 (-1.00%) ▼|CMCSA21.88-0.18 (-0.79%) ▼|COF204.42+2.07 (+1.02%) ▲|COP148.36-3.01 (-1.99%) ▼|COST991.31-13.86 (-1.38%) ▼|CRM243.11-4.51 (-1.82%) ▼|CSCO112.51+2.27 (+2.05%) ▲|CVS91.79-0.74 (-0.80%) ▼|CVX228.00-4.01 (-1.73%) ▼|DE642.51+1.26 (+0.20%) ▲|DHR232.24-0.73 (-0.31%) ▼|DIS109.57-0.83 (-0.75%) ▼|DUK124.02-0.42 (-0.33%) ▼|EMR164.59+2.89 (+1.79%) ▲|FDX304.59+4.01 (+1.33%) ▲|GD356.19-0.86 (-0.24%) ▼|GE295.92+7.49 (+2.60%) ▲|GEV878.92+24.30 (+2.84%) ▲|GILD157.49-1.21 (-0.76%) ▼|GM81.00+4.69 (+6.15%) ▲|GOOG318.16+3.97 (+1.26%) ▲|GOOGL321.77+4.97 (+1.57%) ▲|GS913.08+19.80 (+2.22%) ▲|HD318.22-1.16 (-0.36%) ▼|HON217.13-2.15 (-0.98%) ▼|IBM249.61-3.83 (-1.51%) ▼|INTC93.99+3.52 (+3.89%) ▲|INTU327.03-12.86 (-3.78%) ▼|ISRG444.77-6.86 (-1.52%) ▼|JNJ267.72+1.42 (+0.53%) ▲|JPM336.11+2.07 (+0.62%) ▲|KO92.13-0.57 (-0.61%) ▼|LIN506.81-0.75 (-0.15%) ▼|LLY1,284.53+5.39 (+0.42%) ▲|LMT628.47-6.73 (-1.06%) ▼|LOW197.14-1.09 (-0.55%) ▼|LRCX241.03+3.53 (+1.49%) ▲|MA610.28-3.22 (-0.52%) ▼|MCD248.78-2.06 (-0.82%) ▼|MDLZ62.30-0.67 (-1.06%) ▼|MDT93.80-0.99 (-1.04%) ▼|META624.85-5.71 (-0.91%) ▼|MMM171.51-1.28 (-0.74%) ▼|MO73.36-0.26 (-0.35%) ▼|MRK142.17+1.56 (+1.11%) ▲|MS187.21+3.72 (+2.03%) ▲|MSFT533.73+1.13 (+0.21%) ▲|MU931.42+27.72 (+3.07%) ▲|NEE82.05+0.01 (+0.01%) ▲|NFLX62.71-1.19 (-1.86%) ▼|NKE37.46-0.46 (-1.20%) ▼|NOW155.95-2.24 (-1.41%) ▼|NVDA218.70+2.70 (+1.25%) ▲|ORCL131.76+5.70 (+4.52%) ▲|PEP133.87-1.59 (-1.17%) ▼|PFE29.72-0.08 (-0.25%) ▼|PG158.48-1.44 (-0.90%) ▼|PLTR201.02+2.18 (+1.10%) ▲|PM203.69+1.82 (+0.90%) ▲|QCOM181.20+1.60 (+0.89%) ▲|RTX195.90-1.58 (-0.80%) ▼|SBUX102.49-0.21 (-0.20%) ▼|SCHW89.61-0.12 (-0.13%) ▼|SO91.87-0.70 (-0.76%) ▼|SPG212.30-0.40 (-0.19%) ▼|T21.07+0.22 (+1.03%) ▲|TMO692.74+7.85 (+1.15%) ▲|TMUS146.97+0.04 (+0.03%) ▲|TSLA406.15+14.53 (+3.71%) ▲|TXN306.47+8.35 (+2.80%) ▲|UBER66.13+0.00 (+0.00%) ▲|UNH409.51-1.20 (-0.29%) ▼|UNP297.85+0.88 (+0.29%) ▲|UPS103.36+3.04 (+3.03%) ▲|USB59.74+0.04 (+0.06%) ▲|V400.76-3.40 (-0.84%) ▼|VZ43.84+0.74 (+1.72%) ▲|WFC82.61-0.04 (-0.05%) ▼|WMT118.94-1.36 (-1.13%) ▼|XOM181.09-3.46 (-1.87%) ▼|AAPL346.95+3.04 (+0.88%) ▲|ABBV286.48-0.26 (-0.09%) ▼|ABT103.40-1.48 (-1.41%) ▼|ACN236.25-10.98 (-4.44%) ▼|ADBE251.12-7.50 (-2.90%) ▼|AMAT398.08+10.49 (+2.71%) ▲|AMD558.56+27.28 (+5.13%) ▲|AMGN447.01+2.38 (+0.53%) ▲|AMT185.93-2.35 (-1.25%) ▼|AMZN253.31+4.22 (+1.69%) ▲|AVGO341.61+12.44 (+3.78%) ▲|AXP314.18-0.88 (-0.28%) ▼|BA169.85-18.46 (-9.80%) ▼|BAC50.60+0.08 (+0.16%) ▲|BKNG151.78-1.36 (-0.89%) ▼|BLK1,134.93+7.27 (+0.64%) ▲|BMY61.34-0.27 (-0.44%) ▼|BNY147.83+0.65 (+0.44%) ▲|BRK-B544.77-3.79 (-0.69%) ▼|C122.63+1.59 (+1.31%) ▲|CAT712.52+20.39 (+2.95%) ▲|CL92.17-0.94 (-1.00%) ▼|CMCSA21.88-0.18 (-0.79%) ▼|COF204.42+2.07 (+1.02%) ▲|COP148.36-3.01 (-1.99%) ▼|COST991.31-13.86 (-1.38%) ▼|CRM243.11-4.51 (-1.82%) ▼|CSCO112.51+2.27 (+2.05%) ▲|CVS91.79-0.74 (-0.80%) ▼|CVX228.00-4.01 (-1.73%) ▼|DE642.51+1.26 (+0.20%) ▲|DHR232.24-0.73 (-0.31%) ▼|DIS109.57-0.83 (-0.75%) ▼|DUK124.02-0.42 (-0.33%) ▼|EMR164.59+2.89 (+1.79%) ▲|FDX304.59+4.01 (+1.33%) ▲|GD356.19-0.86 (-0.24%) ▼|GE295.92+7.49 (+2.60%) ▲|GEV878.92+24.30 (+2.84%) ▲|GILD157.49-1.21 (-0.76%) ▼|GM81.00+4.69 (+6.15%) ▲|GOOG318.16+3.97 (+1.26%) ▲|GOOGL321.77+4.97 (+1.57%) ▲|GS913.08+19.80 (+2.22%) ▲|HD318.22-1.16 (-0.36%) ▼|HON217.13-2.15 (-0.98%) ▼|IBM249.61-3.83 (-1.51%) ▼|INTC93.99+3.52 (+3.89%) ▲|INTU327.03-12.86 (-3.78%) ▼|ISRG444.77-6.86 (-1.52%) ▼|JNJ267.72+1.42 (+0.53%) ▲|JPM336.11+2.07 (+0.62%) ▲|KO92.13-0.57 (-0.61%) ▼|LIN506.81-0.75 (-0.15%) ▼|LLY1,284.53+5.39 (+0.42%) ▲|LMT628.47-6.73 (-1.06%) ▼|LOW197.14-1.09 (-0.55%) ▼|LRCX241.03+3.53 (+1.49%) ▲|MA610.28-3.22 (-0.52%) ▼|MCD248.78-2.06 (-0.82%) ▼|MDLZ62.30-0.67 (-1.06%) ▼|MDT93.80-0.99 (-1.04%) ▼|META624.85-5.71 (-0.91%) ▼|MMM171.51-1.28 (-0.74%) ▼|MO73.36-0.26 (-0.35%) ▼|MRK142.17+1.56 (+1.11%) ▲|MS187.21+3.72 (+2.03%) ▲|MSFT533.73+1.13 (+0.21%) ▲|MU931.42+27.72 (+3.07%) ▲|NEE82.05+0.01 (+0.01%) ▲|NFLX62.71-1.19 (-1.86%) ▼|NKE37.46-0.46 (-1.20%) ▼|NOW155.95-2.24 (-1.41%) ▼|NVDA218.70+2.70 (+1.25%) ▲|ORCL131.76+5.70 (+4.52%) ▲|PEP133.87-1.59 (-1.17%) ▼|PFE29.72-0.08 (-0.25%) ▼|PG158.48-1.44 (-0.90%) ▼|PLTR201.02+2.18 (+1.10%) ▲|PM203.69+1.82 (+0.90%) ▲|QCOM181.20+1.60 (+0.89%) ▲|RTX195.90-1.58 (-0.80%) ▼|SBUX102.49-0.21 (-0.20%) ▼|SCHW89.61-0.12 (-0.13%) ▼|SO91.87-0.70 (-0.76%) ▼|SPG212.30-0.40 (-0.19%) ▼|T21.07+0.22 (+1.03%) ▲|TMO692.74+7.85 (+1.15%) ▲|TMUS146.97+0.04 (+0.03%) ▲|TSLA406.15+14.53 (+3.71%) ▲|TXN306.47+8.35 (+2.80%) ▲|UBER66.13+0.00 (+0.00%) ▲|UNH409.51-1.20 (-0.29%) ▼|UNP297.85+0.88 (+0.29%) ▲|UPS103.36+3.04 (+3.03%) ▲|USB59.74+0.04 (+0.06%) ▲|V400.76-3.40 (-0.84%) ▼|VZ43.84+0.74 (+1.72%) ▲|WFC82.61-0.04 (-0.05%) ▼|WMT118.94-1.36 (-1.13%) ▼|XOM181.09-3.46 (-1.87%) ▼|
14.6 C
New York
Tuesday, October 27, 2026

Tag: common

Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

CAMBRIDGE, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the closing of its underwritten public offering of 43,700,000 shares of its common stock, which includes the full exercise of the underwriters’ option to purchase 5,700,000 additional shares of its common stock, at a public offering price of $3.30 per share. The underwriters did not receive any discounts or commissions with respect to an aggregate of 1,818,181 shares of common stock sold to the Cystic Fibrosis Foundation. All of the shares of common stock in the offering were sold by Prime Medicine. The gross proceeds to Prime Medicine from the offering, before deducting underwriting discounts and commissions and offering expenses, were approximately $144.2 million.

AMGEN ANNOUNCES 2025 THIRD QUARTER DIVIDEND

THOUSAND OAKS, Calif., Aug. 1, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for...

DeFi Development Corp. to Host X Spaces Event: “July 2025 Business Recap & AMA”

BOCA RATON, FL, Aug. 01, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”) today announced it will host a live X Spaces conversation on Monday, August 4, 2025, at 1:30 p.m. Eastern Time, titled “July 2025 Business Recap & AMA.”

ITW Board of Directors Approves Dividend Rate Increase

GLENVIEW, Ill., Aug. 01, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Illinois Tool Works Inc. (NYSE: ITW) authorized a seven percent increase to the dividend payout to shareholders, representing a quarterly increase of $0.11 per share – or $0.44 per share annually – versus the current dividend rate. The Board also declared a dividend on the company's common stock of $1.61 per share for the third quarter of 2025. The dividend equates to $6.44 per share on a full-year basis. The dividend will be paid on October 10, 2025 to shareholders of record as of September 30, 2025.

MacKenzie Realty Capital Announces Effective Date for 1-for-10 Reverse Stock Split

MacKenzie Realty Capital Announces Effective Date for 1-for-10 Reverse Stock Split

Xcel Brands Announces Pricing of $2.6 Million Public Offering and Concurrent Management-Led Private Placement

NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Xcel Brands (NASDAQ: XELB), a leading media and consumer products company known for building socially driven, live-commerce-focused brands, today announced the pricing of its public offering of 2,181,818 shares of common stock at a public offering price of $1.10 per share. In a concurrent private placement, the Company also agreed to issue and sell an aggregate of 145,147 unregistered shares to certain insiders of the Company including the Company’s Chief Executive Officer, Robert D'Loren, at a purchase price of $1.36, which is equal to the closing price of the Company’s common stock on July 31, 2025. The closing of the offering is expected to occur on or about August 4, 2025, subject to the satisfaction of customary closing conditions.

Safest SARMs for Muscle Growth in 2025: CrazyBulk Introduces Legal Alternatives to SARMs for Bulking, Cutting, and Strength

CrazyBulk announces safest SARMs for bulking, cutting, and strength in 2025, offering an alternative to traditional anabolic steroids.
CrazyBulk announces safest SARMs for bulking, cutting, and strength in 2025, offering an alternative to traditional anabolic steroids.

SecureTech Announces Uplisting to OTCQB Venture Market

Roseville, Minnesota, Aug. 01, 2025 (GLOBE NEWSWIRE) -- SecureTech Innovations, Inc. (OTCQB: SCTH), a pioneering technology company advancing artificial intelligence, industrial 3D printing and manufacturing technologies, cybersecurity, and digital infrastructure solutions, is pleased to announce that its common stock has been approved for trading on the OTCQB® Venture Market, effective immediately.

CENTURY LITHIUM CLOSES FIRST TRANCHE OF LIFE OFFERING

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR...

NANO Nuclear Selected for Inclusion in the Solactive Global Uranium & Nuclear Components Total Return Index, Qualifying It for Inclusion in the Prominent Global...

With over $4 billion in net assets, the Global X Uranium ETF is the world’s preeminent ETF providing investors broad exposure to companies involved in uranium mining and the production of nuclear components

LT Pro 48 Pickleball Named Official Ball of Carvana PPA Tour

Pickleball designed by Life Time Founder, Chairman and CEO, Bahram Akradi and his engineering team with consistent bounce and durability in mind; Ball available...

Avient Announces Second Quarter 2025 Results

Second quarter sales of $867 million reflect 2% growth over the prior year quarter and includes a favorable impact of 1% from foreign exchangeSecond...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCommon